Select topic…AllAbout NRASApni Jung info for South Asian communityCommunityCOVID-19Diagnosis and MonitoringDiet and ExerciseEventsFamily PlanningFundraisingHealthcare professionalsOther ConditionsResearchSelf-managementSymptoms and CausesTreatmentWork and BenefitsSort byNewest – OldestOldest – Newest News, 06 Dec News from NICE on anti-fibrotic treatment for non-IPF patients NRAS and NICE are pleased to announce that our recent campaign, backed by patients, families and medical experts, to end the inhumane restrictions on a life-extending anti-fibrotic drug for patients with pulmonary fibrosis has been successful. As of 18 October 2021, NICE has agreed that UK doctors will soon be able to prescribe the anti-fibrotic […] News, 17 Sep National Charity launches first of its kind e-learning programme in Rheumatoid Arthritis – SMILE-RA Today, 17 September, 2021, the National Rheumatoid Arthritis Society launches a unique new resource to add to its portfolio of supported self-management programmes, services, publications and digital offerings, called SMILE-RA (Self-Management Individualised Learning Environment in Rheumatoid Arthritis). Rheumatoid Arthritis (>400,000 adults live with RA in the UK) is a serious and complex autoimmune disease characterised […] News, 31 Aug The OCTAVE study results The OCTAVE study results were released on 24 August 2021 and we realise that the initial headlines could cause concern and worry. The study looked at vaccine response of those who are ‘immuno-compromised’ which includes a very wide range of people at varying levels of immune-compression. What the study has shown is that compared to people […] News, 27 Jul HCP Only – GRA physician registry: COVID-19 cases after vaccination If you are a healthcare provider Global Rheumatology Alliance physician registry are looking for patient clinical information on patients with COVID-19 after vaccination. The GRA physician registry is now focusing on patients who develop COVID-19 after their vaccination. If you have these patients, GRA would deeply appreciate if you could take a moment to enter their […] News, 14 Jul Biggest change to treatment of RA since the introduction of biologics in the early 2000s Last month we brought you the news about the Draft Final decision from NICE regarding treatment of ‘moderate active’ RA with some advanced therapies and we’re now delighted to say that as of 14th July this is now Final Guidance. This is an incredible achievement after years of campaigning and has the potential to improve […] News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […] News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […] News, 02 Jan NRAS report on the impact of living with active RA but not being able to access advanced therapies In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies. It […] News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […] News, 10 Mar EULAR issue new guidelines for the management of RA The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016. Previous Page 1 … 8 9 10 11 12 Next Page
News, 06 Dec News from NICE on anti-fibrotic treatment for non-IPF patients NRAS and NICE are pleased to announce that our recent campaign, backed by patients, families and medical experts, to end the inhumane restrictions on a life-extending anti-fibrotic drug for patients with pulmonary fibrosis has been successful. As of 18 October 2021, NICE has agreed that UK doctors will soon be able to prescribe the anti-fibrotic […]
News, 17 Sep National Charity launches first of its kind e-learning programme in Rheumatoid Arthritis – SMILE-RA Today, 17 September, 2021, the National Rheumatoid Arthritis Society launches a unique new resource to add to its portfolio of supported self-management programmes, services, publications and digital offerings, called SMILE-RA (Self-Management Individualised Learning Environment in Rheumatoid Arthritis). Rheumatoid Arthritis (>400,000 adults live with RA in the UK) is a serious and complex autoimmune disease characterised […]
News, 31 Aug The OCTAVE study results The OCTAVE study results were released on 24 August 2021 and we realise that the initial headlines could cause concern and worry. The study looked at vaccine response of those who are ‘immuno-compromised’ which includes a very wide range of people at varying levels of immune-compression. What the study has shown is that compared to people […]
News, 27 Jul HCP Only – GRA physician registry: COVID-19 cases after vaccination If you are a healthcare provider Global Rheumatology Alliance physician registry are looking for patient clinical information on patients with COVID-19 after vaccination. The GRA physician registry is now focusing on patients who develop COVID-19 after their vaccination. If you have these patients, GRA would deeply appreciate if you could take a moment to enter their […]
News, 14 Jul Biggest change to treatment of RA since the introduction of biologics in the early 2000s Last month we brought you the news about the Draft Final decision from NICE regarding treatment of ‘moderate active’ RA with some advanced therapies and we’re now delighted to say that as of 14th July this is now Final Guidance. This is an incredible achievement after years of campaigning and has the potential to improve […]
News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […]
News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […]
News, 02 Jan NRAS report on the impact of living with active RA but not being able to access advanced therapies In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies. It […]
News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […]
News, 10 Mar EULAR issue new guidelines for the management of RA The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016.
Stay up to date Sign up for all the latest RA and NRAS news and receive our regular monthly emails on the latest RA research, events and advice. Sign up